Altamira Therapeutics (CYTO) Stock Forecast for 2023 – 2026. Sell or Buy?
Last update: May 31, 2023 (10:41)Sector: Healthcare
The share price of Altamira Therapeutics Ltd. (CYTO) now
50/200 Day Moving Average: $1.163 / $4.293
This figure corresponds to the Average Price over the previous 50/200 days. For Altamira Therapeutics stocks, the 50-day moving average is the resistance level today.
For Altamira Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Altamira Therapeutics Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Altamira Therapeutics share be worth in 2023 - 2027?
When should I take profit in Altamira Therapeutics stock? When should I record a loss on Altamira Therapeutics stock? What are analysts' forecasts for Altamira Therapeutics stock? What is the future of Altamira Therapeutics stock? We forecast Altamira Therapeutics stock performance using neural networks based on historical data on Altamira Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Altamira Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Altamira Therapeutics shares. This happens once a day.
Historical and forecast chart of Altamira Therapeutics stock
The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Altamira Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Altamira Therapeutics daily forecast for a month
Altamira Therapeutics Daily Price Targets
Altamira Therapeutics Stock Forecast 06-02-2023.
Forecast target price for 06-02-2023: $0.83.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 7.070%.
Pessimistic target level: 0.80
Optimistic target level: 0.87
Altamira Therapeutics Stock Forecast 06-03-2023.
Forecast target price for 06-03-2023: $0.85.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.508%.
Pessimistic target level: 0.83
Optimistic target level: 0.88
Altamira Therapeutics Stock Forecast 06-04-2023.
Forecast target price for 06-04-2023: $0.87.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.386%.
Pessimistic target level: 0.85
Optimistic target level: 0.90
Altamira Therapeutics Stock Forecast 06-05-2023.
Forecast target price for 06-05-2023: $0.86.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.456%.
Pessimistic target level: 0.84
Optimistic target level: 0.88
Altamira Therapeutics Stock Forecast 06-06-2023.
Forecast target price for 06-06-2023: $0.84.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 3.883%.
Pessimistic target level: 0.82
Optimistic target level: 0.86
Altamira Therapeutics Stock Forecast 06-07-2023.
Forecast target price for 06-07-2023: $0.86.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 7.095%.
Pessimistic target level: 0.83
Optimistic target level: 0.89
CYTO (CYTO) Monthly Stock Prediction for 2023
Altamira Therapeutics forecast for this year
Altamira Therapeutics Stock Prediction for Jun 2023
An downtrend is forecast for this month with an optimal target price of $0.792948. Pessimistic: $0.74. Optimistic: $0.83
Altamira Therapeutics Stock Prediction for Jul 2023
An downtrend is forecast for this month with an optimal target price of $0.743785. Pessimistic: $0.69. Optimistic: $0.84
Altamira Therapeutics Stock Prediction for Aug 2023
An downtrend is forecast for this month with an optimal target price of $0.724447. Pessimistic: $0.61. Optimistic: $0.76
Altamira Therapeutics Stock Prediction for Sep 2023
An uptrend is forecast for this month with an optimal target price of $0.776607. Pessimistic: $0.71. Optimistic: $0.82
Altamira Therapeutics Stock Prediction for Oct 2023
An downtrend is forecast for this month with an optimal target price of $0.764181. Pessimistic: $0.68. Optimistic: $0.83
Altamira Therapeutics Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $0.729029. Pessimistic: $0.63. Optimistic: $0.80
Altamira Therapeutics Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $0.784435. Pessimistic: $0.73. Optimistic: $0.91
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2024
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2025
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2026
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2027
Altamira Therapeutics information and performance
Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM 11, BM
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Altamira Therapeutics (CYTO) stock dividend
Altamira Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/01/2019. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.